KindlyMD, Inc. (NASDAQ:NAKA) Short Interest Update

KindlyMD, Inc. (NASDAQ:NAKA) was the target of a large growth in short interest in January. As of January 30th, there was short interest totaling 21,409,965 shares, a growth of 19.8% from the January 15th total of 17,871,354 shares. Based on an average daily trading volume, of 4,733,708 shares, the short-interest ratio is currently 4.5 days. Currently, 5.1% of the shares of the stock are short sold. Currently, 5.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 4,733,708 shares, the short-interest ratio is currently 4.5 days.

KindlyMD Stock Performance

NASDAQ NAKA opened at $0.25 on Thursday. The company has a market cap of $111.46 million, a PE ratio of -0.23 and a beta of 31.46. The firm’s 50 day moving average price is $0.38 and its 200-day moving average price is $2.18. KindlyMD has a 52-week low of $0.25 and a 52-week high of $34.77.

Hedge Funds Weigh In On KindlyMD

A number of large investors have recently added to or reduced their stakes in the company. NewEdge Advisors LLC purchased a new position in shares of KindlyMD in the 4th quarter worth approximately $316,000. Saba Capital Management L.P. acquired a new stake in KindlyMD in the fourth quarter valued at approximately $1,399,000. Millennium Management LLC purchased a new position in KindlyMD in the fourth quarter worth $2,343,000. Hunting Hill Global Capital LLC acquired a new position in shares of KindlyMD during the fourth quarter worth $4,672,000. Finally, Arrington Capital Management LLC purchased a new stake in shares of KindlyMD during the 4th quarter valued at $1,028,000.

Wall Street Analysts Forecast Growth

NAKA has been the topic of several recent analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of KindlyMD in a research note on Monday, December 29th. B. Riley Financial reduced their price objective on shares of KindlyMD from $2.00 to $1.00 and set a “buy” rating on the stock in a research report on Thursday, November 20th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $4.50.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.